|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007610,
umls-concept:C0033414,
umls-concept:C0034786,
umls-concept:C0040715,
umls-concept:C0334227,
umls-concept:C0376358,
umls-concept:C0596290,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C1333931,
umls-concept:C1522702
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-3-1
|
|
pubmed:abstractText |
There are currently few effective therapies for castration-resistant prostate cancer (CRPCa). CRPC which is resistant to castration is thought to result from increased activation of the androgen/androgen receptor (AR) signaling pathway, which may be augmented by AR coactivators.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1097-0045
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
540-54
|
|
pubmed:dateRevised |
2011-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:19938016-Active Transport, Cell Nucleus,
pubmed-meshheading:19938016-Cell Line, Tumor,
pubmed-meshheading:19938016-Cell Nucleus,
pubmed-meshheading:19938016-Cell Proliferation,
pubmed-meshheading:19938016-Histone Acetyltransferases,
pubmed-meshheading:19938016-Humans,
pubmed-meshheading:19938016-Male,
pubmed-meshheading:19938016-Prostatic Neoplasms,
pubmed-meshheading:19938016-Protein Transport,
pubmed-meshheading:19938016-Receptors, Androgen,
pubmed-meshheading:19938016-Transcription, Genetic
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus.
|
|
pubmed:affiliation |
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
